Intron A
(Interferon Alfa-2b)Phase 3Small molecule
Merck & Co.Interferon Alfa-2b is used to treat certain cancers like melanoma and hepatitis C, and some viral infections by helping the immune system fight off disease.[1] Intron A is currently being investigated across 12 indications[3], with its most advanced program in Phase 3.[1]
Intron A is one of 189 small molecule programs targeting Melanoma. It is currently in Phase 3.
12
Indications
27
Total Trials
1
Active Trials
188
Competitors
Pipeline
Status by Indication[3][1]
Indication
Showing 10 of 12 indications
Competition
Competitive Landscape
282 competitors in Multiple Myeloma
#DrugCompanyPhaseTrials
1Fludara
SanofiPhase 3
TALVEY
Johnson & JohnsonPhase 3
Ninlaro
TakedaPhase 3
Sarclisa
AAzienda U.S.L. 1 di Massa e Carrara
Phase 3
Biaxin
AbbViePhase 3
Xpovio
KKaryopharm Therapeutics Inc
Phase 3
Intron A
Merck & Co.Phase 3
Azatiq
KKaruna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
Treanda
AAzurity Pharmaceuticals
Phase 3
Elranatamab
PfizerPhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Melanoma4 trials
Chronic Hepatitis3 trials
Kaposi's sarcoma2 trials
The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma
Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00001114·90 enrolled
16 more indications
Chronic Myelogenous Leukemia1 trial
HIV infection1 trial
Treatment1 trial
Kidney Cancer1 trial
Intraepithelial Neoplasia1 trial
Cutaneous T-cell lymphoma1 trial
Adjuvant Treatment1 trial
Renal Cell Carcinoma1 trial
Adult T-Cell Leukemia/lymphoma1 trial
Pancreatic Cancer1 trial
Hepatitis C1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Interferon Alfa-2b. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Mechanism of Action
- Interferon Alpha/beta Receptor Agonist[2]
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company